Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.
Sector: Services-Testing Laboratories
Industry: Medical - Diagnostics & Research
OTC:FUNI
As of the Aug 31, 2026 FINRA settlement, 5,937 FUNI shares were sold short (<0.01% of a 150.57M-share float, 1.00 days to cover).